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We report the recovery of SalmoneUa typhi that acquired resistance to ampicillin, chloramphenicol,
trimethoprim-sulfamethoxazole, and gentamicin subsequent to multiple antibiotic therapy. Escherichia coli
and KkebsieUa pneumoniae isolates which were recovered from the same stool sample displayed identical
resistance patterns. Agarose gel electrophoresis revealed that S. typhi and laboratory-derived transconijugants
contained a high-molecular-weight plasmid present in the resistant intestinal bacteria.
Typhoid fever caused by Salmonella typhi continues to be
a common endemic illness in developing countries. In the
United States the incidence has decreased, although spo-
radic disease still occurs (4). Travel to an endemic region and
poor sanitary conditions are factors which contribute to
outbreaks (4). In contrast to most enteric pathogens and
other Salmonella species, S. typhi generally remains suscep-
tible to prescribed antibiotic therapy. Chloramphenicol is the
antibiotic of choice, particularly in severely ill patients (4,
21). Ampicillin and trimethoprim-sulfamethoxazole are also
effective agents (12, 23). Resistance to these antimicrobial
agents is usually mediated by R-plasmid transfer. Outbreaks
of infection with chloramphenicol-resistant S. typhi in Mex-
ico, Peru, Vietnam, and elsewhere have been documented
(3, 8, 15, 19), and ampicillin resistance and, less frequently,
trimethoprim-sulfamethoxazole resistance have also been
reported (18, 26). In addition, a combination of resistance to
two of these agents has been reported (5-7); however,
recovery of S. typhi resistant to all three antibiotics is quite
rare (7, 14), and there are no reports of such an isolate in the
United States. The in vivo acquisition of antibiotic resis-
tance in S. typhi from a 25-year-old male in North Carolina
being treated for typhoid fever and having no history of
foreign travel is reported here.
(This work was presented in part at the 86th Annual
Meeting of the American Society for Microbiology, Wash-
ington, D.C., 23 to 28 March 1986.)
Two blood cultures obtained from our patient on admis-
sion were positive for S. typhi (13) which was susceptible to
all antibiotics (S. typhi S). The patient's hospital course was
complicated by an antibiotic (ampicillin)-induced urticarial
rash, and he was sequentially treated with ampicillin (days 1
to 3), chloramphenicol (day 4), and trimethoprim-sulfameth-
oxazole (days 5 to 12) prior to resolution of disease. Broth
macrodilution MICs (11) demonstrated that S. typhi recov-
ered from stool 16 days after the initiation of antibiotic
therapy (S. typhi R) had acquired high-level resistance to
ampicillin, chloramphenicol, and trimethoprim-sulfamethox-
azole (MICs of >128, >128, and >6.75/>128 ,ug/ml, respec-
tively) as well as to gentamicin (MIC of 64 ,ug/ml). Suscep-
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tibilities to other antibiotics, as determined by disk diffusion
(1), were as follows: susceptible-amikacin, cefoxitin, cef-
triaxone, cefuroxime, ciprofloxacin, imipenem, norfloxacin,
and tetracycline; intermediate-amoxicillin-clavulanic acid
(Augmentin) and cefazolin; resistant-cefoperazone, kana-
mycin, mezlocillin, piperacillin, ticarcillin, and tobramycin.
S. typhi R also tested positive for production of P-lactamase.
The S. typhi blood and stool isolates were identical biochem-
ically and were of the same phage type, El (courtesy of J. J.
Farmer III and F. W. Hickman-Brenner, Enteric Bacteriol-
ogy Section, Centers for Disease Control, Atlanta, Ga. [10]).
MICs of ampicillin, chloramphenicol, trimethoprim-sulfa-
methoxazole, and gentamicin for two enteric commensal
organisms, Escherichia coli and Klebsiella pneumoniae,
which were recovered from the same stool sample were
nearly identical (within a twofold dilution) to those for S.
typhi R. Disk diffusion susceptibilities to other tested anti-
biotics were also very similar, with the exception that E. coli
showed resistance to cefoxitin and amoxicillin-clavulanic
acid.
S. typhi R was passed nonselectively (via a daily
"sweep") for 2 weeks on 5% sheep blood agar containing no
antibiotics. Fifty CFU were then individually tested for
antimicrobial susceptibility by the disk diffusion procedure.
All clones remained resistant to ampicillin, chloramphenicol,
trimethoprim-sulfamethoxazole, and gentamicin, indicating
that the resistance phenotype was stably maintained.
A filter mating conjugation procedure was performed to
determine whether resistant stool isolates could transfer
antibiotic resistance to the S. typhi S blood isolate (17).
Rifampin-resistant S. typhi S (selected on plates containing
50 ,ug of rifampin per ml) was added to one of the presumed
donor enteric strains or S. typhi R at a 10:1 ratio (107 S. typhi
and 106 enteric CFU/200 ,ul) and pipetted onto a 25-mm-
diameter nitrocellulose membrane filter that had been placed
on a MacConkey agar plate. The filter was incubated at 37°C
for 2 h. Bacteria were removed from the filter by vortexing in
a tube of sterile saline and cultured on MacConkey plates
containing rifampin (50 ,ug/ml) plus either ampicillin (50
,ug/ml), trimethoprim (2.5 ,ug/ml), sulfamethoxazole (50 ,ug/
ml), or gentamicin (25 ,ug/ml). E. coli, K. pneumoniae, and
S. typhi R were all conjugally proficient; antibiotic resistance
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FIG. 1. Agarose gel electrophoresis of plasmid DNA prepared
from clinical isolates and S. typhi S transconjugants. Plasmids were
separated on a 0.7% agarose gel and stained with ethidium bromide
prior to photography. Lanes: A, R478 marker plasmid (165 mega-
daltons); B, S. typhi S; C, S. typhi R; D, E. coli stool isolate; E, K.
pneumoniae stool isolate; F, S. typhi S transconjugate JPS101 (E.
coli donor); G, S. typhi S transconjugate JPS104 (K. pneumoniae
donor). Acquisition of a single high-molecular-weight plasmid is
indicated by the arrow. chr, Chromosomal DNA.
was transferred to S. typhi S at high frequencies ranging
from 1.4 x 10-2 to 1.2 x 10-1. The transfer frequency of
antibiotic markers was not dependent on the selective agent.
More than 95% of the S. typhi S transconjugants were
resistant to all selected antibiotics, suggesting that genes
coding for antibiotic resistance determinants were closely
linked. Resistance markers were transferred in toto to E. coli
K-12 (kind gift of Ken Bott, University of North Carolina,
Chapel Hill) at a frequency of approximately 7 x 10-3.
Similarly, E. coli K-12 (containing the R factors from K.
pneumoniae) was able to transfer resistance to clinical
isolates of K. pneumoniae, Enterobacter cloacae, and Pseu-
domonas aeruginosa at a frequency of approximately 3 x
lo-3.
Plasmid DNA was extracted from the clinical isolates and
laboratory-derived resistant transconjugants by a rapid alka-
line lysis technique as described by Birnboim and Doly (2).
Electrophoresis on a 0.7% agarose gel and ethidium bromide
staining of plasmid DNA was performed by the procedure of
Maniatis et al. (16). Figure 1 demonstrates acquisition of a
single high-molecular-weight plasmid migrating slightly
faster than the 165-megadalton marker plasmid (kind gift of
D. Taylor, University of Alberta, Edmonton, Alberta, Can-
ada [27]) that was associated with resistance to ampicdillin,
chloramphenicol, trimethoprim, sulfamethoxazole, and gen-
tamicin. The plasmid appeared to have similar molecular
weights in S. typhi R, enteric stool isolates, and S. typhi S
transconjugants JPS101 (E. coli donor) and JPS104 (K.
pneumoniae donor). BamHI restriction enzyme digests of
plasmid DNA purified from strains S. typhi S, JPS101, and
JPS104 (Fig. 2) confirmed that the antibiotic resistance genes
were located on a unique plasmid. Identical restriction
endonuclease patterns were also seen when plasmid DNAs
FIG. 2. BamHI digests of plasmid DNA from S. typhi R (lane A),
JPS101 (lane B), and JPS104 (lane C). Lane D is HindlIl-digested
lambda DNA marker fragments.
from these strains were digested with EcoRl or HindIlI (data
not shown).
The S. typhi isolates recovered from this patient represent
a first reported incidence in the United States of in vivo
acquisition of resistance to all standard first-line antibiotics
for the treatment of typhoid fever. His treatment course
consisted of consecutive administrations of ampicillin, chlor-
amphenicol, and trimethoprim-sulfamethoxazole, suggesting
that these antibiotics played a selective role for the emer-
gence of a resistant organism. Fortunately, our patient had
clinically improved when S. typhi R was recovered from his
stool sample, and the organism was not present upon two
subsequent cultures. It was unknown how this patient ini-
tially acquired S. typhi. He had no identifiable risk factors
such as foreign travel, drinking from a well source, or
contact with diseased individuals.
Accounting for the presence of commensal intestinal flora
which were multiply antibiotic resistant was also uncertain.
Presumably, these organisms also emerged under selective
antibiotic pressure and were the source of transmission of
resistance to S. typhi. Nosocomial transmission of resistance
markers was unlikely, since this novel resistance pattern was
not seen in members of the family Enterobacteriaceae
isolated from North Carolina Memorial Hospital during the
time of his hospital stay.
All antibiotic resistance determinants appeared to reside
on a single large plasmid which was self-transmissible with a
wide host range. Acquisition of drug resistance in vivo by S.
typhi has been reported previously (5, 6, 14, 22); however,
there is only one report of a strain becoming resistant to
ampicillin, chloramphenicol, and trimethoprim-sulfamethox-
azole (14). The isolate we describe differed, because lactose
fermentation was not cotransmissible with drug resistance
(our strain did not ferment lactose) and resistance was stably
maintained. Additionally, all resistance determinants were
conjugally transferred at a high frequency. This plasmid did
not seem to belong to the HIl incompatibility group
(IncHI1), which is most often associated with chloramphen-
icol resistance in S. typhi (20, 25). Like others in this group,
162 NOTES
 on F








the R plasmid was large (greater than 100 megadaltons).
However, the frequency of transfer of drug markers in
IncHIl is temperature susceptible (usually less than 10' at
37°C), and most markers mediate resistance to tetracycline
(24, 25). Moreover, this plasmid was compatible with the
prototype IncHIl plasmid, R27 (9).
This report demonstrated that successive treatment regi-
mens with different antimicrobial agents resulted in selection
of an S. typhi strain resistant to all drugs commonly used for
typhoid fever. Transfer of resistance markers was repro-
duced in vitro by using donor enteric flora recovered from
the same stool sample. Antibiotic therapy should be care-
fully monitored when treating typhoid fever. Physicians and
clinical microbiology laboratories should recognize the po-
tential for emergence of multiply resistant S. typhi.
We thank J. J. Farmer III and F. W. Hickman-Brenner for the
bacteriophage typing data and D. Hone for technical assistance. We
thank P. F. Sparling for editorial review.
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